Coastwise Capital Group’s Moderna MRNA Stock Holding History

Coastwise Capital Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Buy	+3,500	New	+$181K	0.14%	120

Other funds holding MRNA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Morningstar Investment Management Chicago, Illinois $1.62B AUM 13.96% 1-Year Est. Return

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Coastwise Capital Group's MRNA Position: Q2 2026 in Review

Coastwise Capital Group opened a new position in Moderna (MRNA) in Q2 2026: 3,500 shares worth $245K. The stake represents 0.14% of the portfolio and ranks #120 among its holdings.

131 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Coastwise Capital Group held 3,500 shares of Moderna worth $245K as of Q2 2026.
Moderna was a new Coastwise Capital Group position in Q2 2026.
Moderna made up 0.14% of Coastwise Capital Group's portfolio in Q2 2026, its #120 holding.
131 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.